Albert Breier

2.8k total citations
140 papers, 2.4k citations indexed

About

Albert Breier is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Albert Breier has authored 140 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Molecular Biology, 57 papers in Oncology and 14 papers in Organic Chemistry. Recurrent topics in Albert Breier's work include Drug Transport and Resistance Mechanisms (52 papers), Ion Transport and Channel Regulation (13 papers) and Cancer therapeutics and mechanisms (12 papers). Albert Breier is often cited by papers focused on Drug Transport and Resistance Mechanisms (52 papers), Ion Transport and Channel Regulation (13 papers) and Cancer therapeutics and mechanisms (12 papers). Albert Breier collaborates with scholars based in Slovakia, Czechia and Russia. Albert Breier's co-authors include Zdena Sulová, Miroslav Barančı́k, Mário Šereš, Lenka Gibalová, A Ziegelhöffer, B Uhrík, Peter Gemeiner, Boris Lakatoš, Oľga Križanová and Ján Sedlák and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

Albert Breier

138 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Breier Slovakia 27 1.4k 869 183 178 167 140 2.4k
Annarica Calcabrini Italy 30 1.3k 0.9× 832 1.0× 237 1.3× 83 0.5× 86 0.5× 86 2.5k
Amin A. Nomeir United States 28 834 0.6× 682 0.8× 181 1.0× 189 1.1× 116 0.7× 111 2.7k
J. Fred Nagelkerke Netherlands 32 1.4k 1.0× 647 0.7× 311 1.7× 147 0.8× 182 1.1× 87 3.6k
Sandra Incerpi Italy 29 1.1k 0.8× 291 0.3× 190 1.0× 140 0.8× 275 1.6× 105 2.8k
Shigeki Tsuchida Japan 30 2.3k 1.6× 631 0.7× 358 2.0× 58 0.3× 144 0.9× 116 3.2k
Howard L. Elford United States 26 1.2k 0.9× 708 0.8× 188 1.0× 58 0.3× 131 0.8× 76 2.4k
Guy G. Chabot France 32 1.6k 1.1× 712 0.8× 145 0.8× 79 0.4× 92 0.6× 67 3.1k
Elaine L. Jacobson United States 43 2.5k 1.7× 2.3k 2.7× 167 0.9× 114 0.6× 338 2.0× 91 5.3k
Teruo Amachi Japan 37 2.0k 1.4× 729 0.8× 94 0.5× 142 0.8× 152 0.9× 94 3.6k
Scott J. Weir United States 29 928 0.7× 560 0.6× 301 1.6× 157 0.9× 132 0.8× 106 2.2k

Countries citing papers authored by Albert Breier

Since Specialization
Citations

This map shows the geographic impact of Albert Breier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Breier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Breier more than expected).

Fields of papers citing papers by Albert Breier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Breier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Breier. The network helps show where Albert Breier may publish in the future.

Co-authorship network of co-authors of Albert Breier

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Breier. A scholar is included among the top collaborators of Albert Breier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Breier. Albert Breier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Šereš, Mário, et al.. (2025). Do wolframin, P-glycoprotein, and GRP78/BiP cooperate to alter the response of L1210 cells to endoplasmic reticulum stress or drug sensitivity?. Cancer Cell International. 25(1). 35–35. 2 indexed citations
3.
Kaliňáková, Barbora, et al.. (2024). The Antimicrobial Effects of Myrosinase Hydrolysis Products Derived from Glucosinolates Isolated from Lepidium draba. Plants. 13(7). 995–995. 2 indexed citations
4.
Poturnayová, Alexandra, et al.. (2024). New Insights into Aptamers: An Alternative to Antibodies in the Detection of Molecular Biomarkers. International Journal of Molecular Sciences. 25(13). 6833–6833. 53 indexed citations
5.
Sulová, Zdena, et al.. (2023). Resistance of Leukemia Cells to 5-Azacytidine: Different Responses to the Same Induction Protocol. Cancers. 15(11). 3063–3063. 2 indexed citations
6.
Olejníková, Petra, et al.. (2023). Synthesis of Pyrazoloazepines from 5‐Aminopyrazoles and Study of Their Cytotoxicity in Cancer Treatment. European Journal of Organic Chemistry. 26(25).
7.
Rebroš, Martin, et al.. (2022). Effects of Sulforaphane-Induced Cell Death upon Repeated Passage of Either P-Glycoprotein-Negative or P-Glycoprotein-Positive L1210 Cell Variants. International Journal of Molecular Sciences. 23(18). 10818–10818. 3 indexed citations
8.
Šereš, Mário, et al.. (2022). The Roles of microRNAs in Cancer Multidrug Resistance. Cancers. 14(4). 1090–1090. 36 indexed citations
9.
10.
Breier, Albert, et al.. (2021). Optimisation of Recombinant Myrosinase Production in Pichia pastoris. International Journal of Molecular Sciences. 22(7). 3677–3677. 15 indexed citations
11.
Mišák, Anton, et al.. (2021). Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells. International Journal of Molecular Sciences. 22(11). 5504–5504. 5 indexed citations
13.
Šereš, Mário, et al.. (2020). Development of Resistance to Endoplasmic Reticulum Stress-Inducing Agents in Mouse Leukemic L1210 Cells. Molecules. 25(11). 2517–2517. 7 indexed citations
14.
Poturnayová, Alexandra, et al.. (2020). Cell Death Effects Induced by Sulforaphane and Allyl Isothiocyanate on P-Glycoprotein Positive and Negative Variants in L1210 Cells. Molecules. 25(9). 2093–2093. 11 indexed citations
16.
Lakatoš, Boris, et al.. (2018). Detection of the Mitochondrial Membrane Potential by the Cationic Dye JC-1 in L1210 Cells with Massive Overexpression of the Plasma Membrane ABCB1 Drug Transporter. International Journal of Molecular Sciences. 19(7). 1985–1985. 151 indexed citations
17.
Tomášová, Lenka, et al.. (2018). Interplay between P-Glycoprotein Expression and Resistance to Endoplasmic Reticulum Stressors. Molecules. 23(2). 337–337. 40 indexed citations
18.
Šereš, Mário, et al.. (2017). L1210 Cells Overexpressing ABCB1 Drug Transporters Are Resistant to Inhibitors of the N- and O-glycosylation of Proteins. Molecules. 22(7). 1104–1104. 7 indexed citations
19.
Barančı́k, Miroslav, et al.. (2001). Drug transporters and their role in multidrug resistance of neoplastic cells.. PubMed. 20(3). 215–37. 39 indexed citations
20.
Barančı́k, Miroslav, et al.. (1996). Overcoming of P-glycoprotein mediated vincristine resistance of L1210/VCR mouse leukemic cells could be induced by pentoxifyline but not by theophylline and caffeine.. PubMed. 43(1). 11–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026